BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 21204700)

  • 1. Rapid and cost-effective method for the detection of the c.533G>A mutation in the HEXA gene.
    Ribeiro D; Duarte AJ; Amaral O
    Genet Test Mol Biomarkers; 2011 Mar; 15(3):123-6. PubMed ID: 21204700
    [TBL] [Abstract][Full Text] [Related]  

  • 2. GM2 gangliosidoses in Spain: analysis of the HEXA and HEXB genes in 34 Tay-Sachs and 14 Sandhoff patients.
    Gort L; de Olano N; MacĂ­as-Vidal J; Coll MA;
    Gene; 2012 Sep; 506(1):25-30. PubMed ID: 22789865
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular analysis of the HEXA gene in Italian patients with infantile and late onset Tay-Sachs disease: detection of fourteen novel alleles.
    Montalvo AL; Filocamo M; Vlahovicek K; Dardis A; Lualdi S; Corsolini F; Bembi B; Pittis MG
    Hum Mutat; 2005 Sep; 26(3):282. PubMed ID: 16088929
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prenatal Diagnosis of Tay-Sachs Disease.
    Zhang J; Chen H; Kornreich R; Yu C
    Methods Mol Biol; 2019; 1885():233-250. PubMed ID: 30506202
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An A-to-G mutation at the +3 position of intron 8 of the HEXA gene is associated with exon 8 skipping and Tay-Sachs disease.
    Richard MM; Erenberg G; Triggs-Raine BL
    Biochem Mol Med; 1995 Jun; 55(1):74-6. PubMed ID: 7551830
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Specificity and sensitivity of hexosaminidase assays and DNA analysis for the detection of Tay-Sachs disease gene carriers among Ashkenazic Jews.
    Fernandes MJ; Kaplan F; Clow CL; Hechtman P; Scriver CR
    Genet Epidemiol; 1992; 9(3):169-75. PubMed ID: 1387862
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular analysis of HEXA gene in Argentinean patients affected with Tay-Sachs disease: possible common origin of the prevalent c.459+5A>G mutation.
    Zampieri S; Montalvo A; Blanco M; Zanin I; Amartino H; Vlahovicek K; Szlago M; Schenone A; Pittis G; Bembi B; Dardis A
    Gene; 2012 May; 499(2):262-5. PubMed ID: 22441121
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A mutation common in non-Jewish Tay-Sachs disease: frequency and RNA studies.
    Akerman BR; Zielenski J; Triggs-Raine BL; Prence EM; Natowicz MR; Lim-Steele JS; Kaback MM; Mules EH; Thomas GH; Clarke JT
    Hum Mutat; 1992; 1(4):303-9. PubMed ID: 1301938
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Improving accuracy of Tay Sachs carrier screening of the non-Jewish population: analysis of 34 carriers and six late-onset patients with HEXA enzyme and DNA sequence analysis.
    Park NJ; Morgan C; Sharma R; Li Y; Lobo RM; Redman JB; Salazar D; Sun W; Neidich JA; Strom CM
    Pediatr Res; 2010 Feb; 67(2):217-20. PubMed ID: 19858779
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tay-Sachs disease in an Arab family due to c.78G>A HEXA nonsense mutation encoding a p.W26X early truncation enzyme peptide.
    Haghighi A; Masri A; Kornreich R; Desnick RJ
    Mol Genet Metab; 2011 Dec; 104(4):700-2. PubMed ID: 21967858
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of novel mutations in HEXA gene in children affected with Tay Sachs disease from India.
    Mistri M; Tamhankar PM; Sheth F; Sanghavi D; Kondurkar P; Patil S; Idicula-Thomas S; Gupta S; Sheth J
    PLoS One; 2012; 7(6):e39122. PubMed ID: 22723944
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of enzyme and DNA analysis in a Tay-Sachs disease carrier screening program.
    Yoo HW; Astrin KH; Desnick RJ
    J Korean Med Sci; 1993 Feb; 8(1):84-91. PubMed ID: 8343225
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tay-Sachs disease carrier screening: a model for prevention of genetic disease.
    Kaplan F
    Genet Test; 1998; 2(4):271-92. PubMed ID: 10464605
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tay-Sachs disease screening and diagnosis: evolving technologies.
    Hechtman P; Kaplan F
    DNA Cell Biol; 1993 Oct; 12(8):651-65. PubMed ID: 8397824
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rapid identification of HEXA mutations in Tay-Sachs patients.
    Giraud C; Dussau J; Azouguene E; Feillet F; Puech JP; Caillaud C
    Biochem Biophys Res Commun; 2010 Feb; 392(4):599-602. PubMed ID: 20100466
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Screening for Tay-Sachs disease carriers by full-exon sequencing with novel variant interpretation outperforms enzyme testing in a pan-ethnic cohort.
    Cecchi AC; Vengoechea ES; Kaseniit KE; Hardy MW; Kiger LA; Mehta N; Haque IS; Moyer K; Page PZ; Muzzey D; Grinzaid KA
    Mol Genet Genomic Med; 2019 Aug; 7(8):e836. PubMed ID: 31293106
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tay-Sachs disease-causing mutations and neutral polymorphisms in the Hex A gene.
    Myerowitz R
    Hum Mutat; 1997; 9(3):195-208. PubMed ID: 9090523
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Common HEXB polymorphisms reduce serum HexA and HexB enzymatic activities, potentially masking Tay-Sachs disease carrier identification.
    Vallance H; Morris TJ; Coulter-Mackie M; Lim-Steele J; Kaback M
    Mol Genet Metab; 2006 Feb; 87(2):122-7. PubMed ID: 16352452
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rapid detection of fetal Mendelian disorders: Tay-Sachs disease.
    Guetta E; Peleg L
    Methods Mol Biol; 2008; 444():147-59. PubMed ID: 18425478
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tay-Sachs Disease: Two Novel Rare HEXA Mutations from Pakistan and Morocco.
    Bibi F; Ullah A; Bourinaris T; Efthymiou S; Kriouile Y; Sultan T; Haider S; Salpietro V; Houlden H; Kaukab Raja G
    Klin Padiatr; 2021 Sep; 233(5):226-230. PubMed ID: 33831955
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.